Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Novel Small Molecule Drug Entities Targeting Aminergic G Protein-Coupled Receptors


Technology Benefits

The drug entities:ΓÇóAre non-toxic and highly efficientΓÇóAre capable of reversing a variety of disrupted cognitive/behavioral processesΓÇóDo not cause undesirable side effects as observed with conventional therapiesΓÇóHave a unique 5HT2A/2B receptor inverse agonist/antagonist activity together with 5HT2C receptor agonist activity in the same monovalent small moleculeΓÇóDo not have stimulant or sedative properties and are unlikely to be addictive as compared to conventional therapiesΓÇóWould be commercially useful for treatment of various neuropsychiatric, cardiovascular, and metabolic disorders


Detailed Technology Description

None


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View